Drug Topics - February 2009 - (Page 4)

CONTENTS CLINICAL 28 SPECIAL REPORT ORAL ONCOLOGY DRUGS Dispensing, billing, and reimbursment problems sometimes accompany these agents CONTINUING EDUCATION 40 50 NEW DRUGS UPDATE 2008 APPROVALS OTC Products that relieve sore-throat discomfort NEW PRODUCTS Abbott’s Trilipix delayed-release capsules approved by FDA PRODUCT UPDATES 40 53 50 53 ystem Health-S n Editio Opposite p 8 Attention acists spital Pharm Ho Health-System Edition H1 COVER STORY Group attempts to resurrect Pain Care Act H2 HSE Business Management New index ranks hospital pharmacy performance H6 HSE Clinical Off-label prescribing lacks evidence H1 Drug Topics (ISSN# 0012-6616) is published monthly and Drug Topics Digital Edition (ISSN# 1937-8157) is issued every week by Advanstar Communications, Inc., 131 West First St., Duluth, MN 55806-2065. One-year subscription rates: $61 in the United States & Possessions; $109 in Canada and Mexico; all other countries, $109. Single copies (prepaid only) $10 in the United States; $10 in Canada and Mexico; all other countries, $15. Include $6 per copy for U.S. postage and handling. Periodicals postage paid at Duluth, MN 55806 and additional mailing of ces. POSTMASTER: Please send address changes to Drug Topics, P .O. Box 6079, Duluth, MN 55806-6079. Canadian G.S.T. number: R-124213133RT001. Publications Mail Agreement Number 40017597. Printed in the U.S.A. Subscription inquiries/address changes: tollfree (888) 527-7008, or dial direct (218) 723-9477. ©2009 Advanstar Communications Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/educational or personal use, or the internal/educational or personal use of speci c clients is granted by Advanstar Communications Inc. for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700. For uses beyond those listed above, please direct your written request to Permission Dept. fax 440-891-2650 or email: bgilbert@ advanstar.com. Micro lm or micro che copies of issues are available through Advanstar Marketing Services, (800) 225-4569, Ext. 839. Unsolicited manuscripts, photographs, art, and other material will not be returned. Publisher assumes no responsibility for unsolicited manuscripts, photographs, art, and other material. Advanstar Communications provides certain customer contact data (such as customers’ names, addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call toll-free (888) 527-7008 between the hours of 7:30 am and 5 pm CT and a customer service representative will assist you in removing your name from Advanstar’s lists. Outside the U.S., please phone (218) 723-9477. DRUG TOPICS does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance on such content. DRUG TOPICS welcomes unsolicited articles, manuscripts, photographs and other materials but cannot be held responsible for their safekeeping or return. 4 DRUG TOPICS Februar y 2009 W W W.D R U GTO P I C S .C O M http://www.advanstar.com http://WWW.DRUGTOPICS.COM

Table of Contents Feed for the Digital Edition of Drug Topics - February 2009

Drug Topics - February 2009 Contents Health-System Edition Group Attempts to Resurrect Pain Care Act HSE Business Management HSE Clinical Letters Up Front Up Front in Depth Community Practice Niche Pharmacies Serve Special Populations Special Report Oral Oncology Drugs New Drugs Update 2008 Approvals OTC New Products Viewpoint

Drug Topics - February 2009

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.